Eterna Therapeutics (ERNA)
4.45
-0.09 (1.98%)
Upcoming Events
Latest Headlines
Three Biotechs Deliver Catalysts to Watch
July 15, 2026 10:43 AM - StreetInsider
Ernexa's ERNA-101 combo shows tumor clearance in animal study
July 15, 2026 7:50 AM - StreetInsider
Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry
July 15, 2026 7:50 AM - StreetInsider
Ernexa targets Q4 2026 for first-in-human ovarian cancer trial
July 14, 2026 9:01 AM - StreetInsider
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
July 14, 2026 9:01 AM - StreetInsider
Form 8-K Ernexa Therapeutics Inc. For: Jul 02
July 2, 2026 4:41 PM - SEC Filing
Form 8-K Ernexa Therapeutics Inc. For: Jul 01
July 2, 2026 4:31 PM - SEC Filing
Form 8-K Ernexa Therapeutics Inc. For: Jun 22
June 26, 2026 4:31 PM - SEC Filing
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
June 25, 2026 9:15 AM - StreetInsider
Ernexa Therapeutics plans IND filing for cancer cell therapy in Q3 2026
June 17, 2026 8:48 AM - StreetInsider
Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study
June 17, 2026 8:47 AM - StreetInsider
Ernexa highlights ovarian cancer treatment challenges in investor segment
June 9, 2026 8:41 AM - StreetInsider
Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
June 9, 2026 8:41 AM - StreetInsider
Ernexa Therapeutics completes manufacturing milestones for ERNA-101
May 27, 2026 8:11 AM - StreetInsider
Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development
May 27, 2026 8:11 AM - StreetInsider
Form SCHEDULE 13G/A Ernexa Therapeutics Inc. Filed by: CLEAR STREET LLC
May 20, 2026 4:51 PM - SEC Filing
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
May 20, 2026 8:31 AM - Globe NewsWire
Form SCHEDULE 13G/A Ernexa Therapeutics Inc. Filed by: Freebird Partners LP
May 15, 2026 8:54 PM - SEC Filing
Form SCHEDULE 13G/A Ernexa Therapeutics Inc. Filed by: HALPERN JOHN D
May 15, 2026 8:50 PM - SEC Filing
Form SCHEDULE 13G Ernexa Therapeutics Inc. Filed by: Bleichroeder LP
May 14, 2026 5:46 PM - SEC Filing
Form SCHEDULE 13G Ernexa Therapeutics Inc. Filed by: CLEAR STREET LLC
May 14, 2026 12:31 PM - SEC Filing
Form SCHEDULE 13G/A Ernexa Therapeutics Inc. Filed by: Konar Shameek
May 13, 2026 9:49 PM - SEC Filing
Form ARS Ernexa Therapeutics Inc. For: Dec 31
May 11, 2026 5:18 PM - SEC Filing
Form DEFA14A Ernexa Therapeutics Inc.
May 11, 2026 5:12 PM - SEC Filing
Form DEF 14A Ernexa Therapeutics Inc. For: May 11
May 11, 2026 5:10 PM - SEC Filing
Form 10-Q Ernexa Therapeutics Inc. For: Mar 31
May 11, 2026 5:02 PM - SEC Filing
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101
May 11, 2026 9:15 AM - Globe NewsWire
Brookline Capital Markets Starts Ernexa Therapeutics (ERNA) at Buy
May 7, 2026 3:23 PM - StreetInsider
Ernexa Therapeutics reports complete tumor elimination in ovarian cancer study
May 6, 2026 8:33 AM - StreetInsider
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
May 6, 2026 8:33 AM - Globe NewsWire
Form 8-K Ernexa Therapeutics Inc. For: May 01
May 4, 2026 4:11 PM - SEC Filing
Ernexa Therapeutics announces 1-for-25 reverse stock split
April 30, 2026 9:01 AM - StreetInsider
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
April 30, 2026 9:00 AM - StreetInsider
Full Article List
